A. Hyseni

发表

Active von Willebrand factor and the risk of stroke.

P. D. de Groot, P. Lenting, F. Leebeek, 2010, Atherosclerosis.

The anticoagulant effect of heparin during radiofrequency ablation (RFA) in patients taking apixaban or rivaroxaban

I. Ott, B. Steppich, M. Roest, 2017, Journal of Interventional Cardiac Electrophysiology.

Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients.

A. Kastrati, G. Ndrepepa, P. D. de Groot, 2013, Thrombosis research.

Sustained pro-haemostatic activity of rFVIIa in plasma and platelets in non-bleeding pigs may explain the efficacy of a once-daily prophylaxis in humans

P. D. de Groot, J. Meijers, T. Lisman, 2014, Thrombosis and Haemostasis.

Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation

I. Ott, I. Deisenhofer, B. Steppich, 2017, Journal of Thrombosis and Thrombolysis.

A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)

D. Klonoff, E. Renard, M. Evans, 2019, Diabetes, obesity & metabolism.

KEYNOTE - D36: personalized immunotherapy with a neoepitope vaccine, EVX-01 and pembrolizumab in advanced melanoma.

P. Ott, Thomas Trolle, G. Long, 2022, Future oncology.

Active von Willebrand factor predicts 28-day mortality in patients with systemic inflammatory response syndrome.

D. D. de Lange, P. D. de Groot, J. Kesecioglu, 2014, Blood.

von Willebrand factor activation, granzyme‐B and thrombocytopenia in meningococcal disease

L. Joosten, P. D. de Groot, P. Lenting, 2010, Journal of thrombosis and haemostasis : JTH.

A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A

V. Jiménez‐Yuste, H. Eichler, K. Kavaklı, 2018, Journal of thrombosis and haemostasis : JTH.

CLINICAL TRIALS AND OBSERVATIONS Active von Willebrand factor predicts 28-day mortality in patients with systemic in ﬂ ammatory response syndrome

J. Kesecioglu, M. Roest, H. Kemperman, 2014 .

Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression

P. V. van Diest, E. van der Wall, P. van der Groep, 2011, Cellular Oncology.

Increased mortality in systemic inflammatory response syndrome patients with high levels of coagulation factor VIIa

J. Kesecioglu, M. Linssen, M. Roest, 2013, Journal of thrombosis and haemostasis : JTH.